Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase

BACKGROUND: Hyperbaric oxygen therapy (HBOT) is a known adjuvant for treating ischemia-related inner ear diseases. Controversies still exist in the role of HBOT in cochlear diseases. Few studies to date have investigated the cellular changes that occur in inner ears after HBOT. Nitric oxide, which i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chia-Der, Wei, I-Hua, Lai, Chih-Ho, Hsia, Te-Chun, Kao, Ming-Ching, Tsai, Ming-Hsui, Wu, Ching-Hsiang, Tsai, Mang-Hung
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050772/
https://www.ncbi.nlm.nih.gov/pubmed/21342510
http://dx.doi.org/10.1186/1471-2202-12-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050772/
https://www.ncbi.nlm.nih.gov/pubmed/21342510
http://dx.doi.org/10.1186/1471-2202-12-21

Ejemplares similares